Home LiteratureArticle Details
PMID: 15148568 Published · ppublish English Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Practices in non-neutropenic ICU patients with Candida-positive airway specimens.

Intensive care medicine ·Vol. 30 ·No. 7 ·2004-07-00 ·Pages 1384-9

Azoulay E, Cohen Y, Zahar JR, Garrouste-Orgeas M, Adrie C, Moine P, de Lassence A, Timsit JF

Abstract

To examine practices of French intensivists regarding the management of mechanically ventilated patients with Candida-positive airway specimens but no major risk factors for immunodepression. Design : Closed-item questionnaire with a clinical vignette. 564 French intensive care units (ICUs). 198 intensivists who have a special interest in infectious diseases and who answered the questionnaire (response rate, 35.1%). None. The respondents recommended bronchoalveolar lavage (62.6% of respondents), protected distal sampling and protected specimen brush (59.1%), transbronchial biopsy (38.9%), and tracheal aspiration (12.1%) for the diagnosis of candidal pneumonia. A positive airway specimen was felt by most respondents (83.3%) to indicate colonisation; 66.7% of respondents recommended tests for systemic candidiasis in this situation, and 56.5% serial sampling to compute the colonisation index. Azole derivatives were the preferred antifungal medications. The clinical vignette described a patient with chronic obstructive lung disease who required mechanical ventilation for an acute exacerbation and who had a tracheal aspirate positive for Candida. Responses varied widely, with 37.8% of respondents diagnosing clinically insignificant colonisation but 24.2% recommending antifungal treatment and 61.6% serial testing to assess the Candida colonisation index. Intensivists with greater experience with severely immunocompromised patients were more aggressive in their diagnostic management. Wide variations occur among practices of French intensivists regarding Candida-positive airway specimens in patients without major risk factors for immunodepression. Additional studies are needed to improve our understanding of the links between Candida colonisation and infection and to determine the indications for pre-emptive antifungal treatment in non-neutropenic critically ill patients.

MeSH Terms
Antifungal Agents/therapeutic use Candida/drug effects,isolation & purification Candidiasis/diagnosis,drug therapy,etiology France Humans Intensive Care Units Lung Diseases, Fungal/diagnosis,drug therapy,etiology Pneumonia/diagnosis,drug therapy,microbiology Pulmonary Disease, Chronic Obstructive/therapy Respiration, Artificial/adverse effects,methods Surveys and Questionnaires
Chemicals
Antifungal Agents
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Azoulay Elie
Intensive Care Unit, Saint Louis Teaching Hospital, 1 Avenue Claude Vellefaux, 75010 Paris, France. [email protected]
Cohen Yves
Zahar Jean-Ralph
Garrouste-Orgeas Maité
Adrie Christophe
Moine Pierre
de Lassence Arnaud
Timsit Jean-François
References (31)
31 references, click to expand
  1. Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors.
    Chest. 2001 Jul;120(1):177-84 PMID: 11451835
  2. Mechanisms for the diminished neutrophil exudation to secondary inflammatory sites in infected patients with a systemic inflammatory response (sepsis).
    Crit Care Med. 1999 Nov;27(11):2459-68 PMID: 10579265
  3. Candida sepsis in surgical patients.
    Am J Surg. 1993 Dec;166(6):617-9; discussion 619-20 PMID: 8273839
  4. Candidiasis in cancer patients.
    Am J Med. 1984 Oct 30;77(4D):13-9 PMID: 6093529
  5. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.
    JAMA. 1995 Aug 23-30;274(8):639-44 PMID: 7637145
  6. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care.
    Intensive Care Med. 1998 Mar;24(3):206-16 PMID: 9565801
  7. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study.
    Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):583-90 PMID: 9279244
  8. Primary Candida pneumonia. Experience at a large cancer center and review of the literature.
    Medicine (Baltimore). 1993 May;72(3):137-42 PMID: 8502166
  9. Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients.
    Crit Care Med. 2002 Feb;30(2):315-22 PMID: 11889301
  10. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.
    Ann Intern Med. 1993 Apr 1;118(7):495-503 PMID: 8442620
  11. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research.
    Intensive Care Med. 1997 Mar;23(3):317-25 PMID: 9083235
  12. Immunomodulatory therapies in sepsis.
    Intensive Care Med. 2000;26 Suppl 1:S124-8 PMID: 10786969
  13. Antifungal prophylaxis for intensive care unit patients: let's fine tune it.
    Intensive Care Med. 2002 Dec;28(12):1698-1700 PMID: 12580153
  14. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
    N Engl J Med. 1992 Mar 26;326(13):845-51 PMID: 1542320
  15. Epidemiology of nosocomial fungal infections, with emphasis on Candida species.
    Clin Infect Dis. 1995 Jun;20(6):1526-30 PMID: 7548503
  16. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination.
    Intensive Care Med. 2002 Dec;28(12):1708-17 PMID: 12447512
  17. Risk factors for hospital-acquired candidemia. A matched case-control study.
    Arch Intern Med. 1989 Oct;149(10):2349-53 PMID: 2802900
  18. [Candidiasis among non-neutropenic patients: from colonization to infection].
    Ann Fr Anesth Reanim. 2001 Apr;20(4):382-8 PMID: 11392250
  19. Candida colonization and subsequent infections in critically ill surgical patients.
    Ann Surg. 1994 Dec;220(6):751-8 PMID: 7986142
  20. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
    Clin Infect Dis. 2002 Jan 1;34(1):7-14 PMID: 11731939
  21. Pulmonary candidiasis. A clinical and pathological correlation.
    Arch Intern Med. 1978 Jun;138(6):964-5 PMID: 646568
  22. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Clin Infect Dis. 2000 Apr;30(4):662-78 PMID: 10770728
  23. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients.
    Ann Surg. 2001 Apr;233(4):542-8 PMID: 11303137
  24. Infection and diabetes mellitus.
    Diabetes Care. 1980 Jan-Feb;3(1):187-97 PMID: 6996964
  25. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units.
    Clin Infect Dis. 1999 Aug;29(2):253-8 PMID: 10476721
  26. High alcohol intake as a risk and prognostic factor for community-acquired pneumonia.
    Arch Intern Med. 1995 Aug 7-21;155(15):1649-54 PMID: 7618989
  27. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.
    Clin Infect Dis. 2002 Sep 1;35(5):627-30 PMID: 12173140
  28. Prophylactic antifungal therapy in the intensive care unit.
    Clin Infect Dis. 2001 Apr 15;32(8):1191-200 PMID: 11283809
  29. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.
    Crit Care Med. 1999 Jun;27(6):1066-72 PMID: 10397206
  30. The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients.
    Chest. 1998 Jul;114(1):146-9 PMID: 9674461
  31. Pulmonary disease caused by Candida species.
    Am J Med. 1977 Dec;63(6):914-25 PMID: 343588
Article Info
Journal
Intensive care medicine
Abbr.
Intensive Care Med
ISSN
0342-4642
Published
2004-07-00
Epub
2004-00-18
Pages
1384-9
Language
English
Region
United States
NLM ID
7704851
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]